| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/13/2000 | CA2344456A1 Ptans: testis specific proteins expressed in prostate cancer |
| 04/13/2000 | CA2344269A1 Therapeutically active proteins in plants |
| 04/13/2000 | CA2344266A1 Cadherin-like asymmetry protein-1, and methods for its use |
| 04/13/2000 | CA2343698A1 Repair of larynx, trachea, and other fibrocartilaginous tissues |
| 04/13/2000 | CA2341351A1 Alpha-2/delta gene |
| 04/13/2000 | CA2335391A1 Akt compositions for enhancing survival of cells |
| 04/13/2000 | CA2313169A1 Engraftable neural progenitor and stem cells for brain tumor therapy |
| 04/12/2000 | EP0992587A2 High affinity IP3-binding polypeptide |
| 04/12/2000 | EP0992585A2 Human calcium channel compositions and methods |
| 04/12/2000 | EP0992584A2 Purified mammalian FLT3 ligands and agonists and antagonists thereof |
| 04/12/2000 | EP0992579A1 Stem cell factor |
| 04/12/2000 | EP0992492A1 Small molecule inhibitors of rotamase enzyme activity |
| 04/12/2000 | EP0992243A1 Prophylactic/remedial agent |
| 04/12/2000 | EP0991770A2 Prostate cancer gene |
| 04/12/2000 | EP0991760A1 Tumor growth inhibition- and apoptosis-associated genes and polypeptides and methods of use thereof |
| 04/12/2000 | EP0991759A1 Ntn-2 member of tnf ligand family |
| 04/12/2000 | EP0991758A1 Smad6 and uses thereof |
| 04/12/2000 | EP0991757A1 Novel tumor antigens |
| 04/12/2000 | EP0991756A2 Agents for the pre-symptomatic detection, prevention and treatment of breast cancer in humans |
| 04/12/2000 | EP0991755A1 Oligonucleotide mediated specific cytokine induction and in vivo protection from infection |
| 04/12/2000 | EP0991753A1 Protease inhibitors |
| 04/12/2000 | EP0991666A1 Alpha 1-antitrypsin preparation and method for the production thereof |
| 04/12/2000 | EP0991665A1 Peptides and compounds that bind to the il-5 receptor |
| 04/12/2000 | EP0991664A1 Novel pharmaceutically active compounds interacting with gtp-binding proteins |
| 04/12/2000 | EP0991661A2 Chimeric interleukin-6 soluble receptor/ligand protein, analogs thereof and uses thereof |
| 04/12/2000 | EP0991660A1 Deuterated cyclosporine analogs and their use as immunomodulating agents |
| 04/12/2000 | EP0991659A1 Peptides and compounds that bind to the il-5 receptor |
| 04/12/2000 | EP0991658A1 Dolastatin 15 derivatives |
| 04/12/2000 | EP0991647A1 Eprosartan monohydrate |
| 04/12/2000 | EP0991426A1 Improved method for transferring nucleic acid into the striped muscle and combination therefor |
| 04/12/2000 | EP0991424A1 Pharmaceutical compositions comprising an aldose reductase inhibitor and an ace inhibitor |
| 04/12/2000 | EP0991423A1 Topical treatment of psoriasis using neutralizing antibodies to il-8 |
| 04/12/2000 | EP0991422A1 Modulating epithelial-mesenchymal interactions |
| 04/12/2000 | EP0991421A2 Detection and modulation of the iaps and naip for the diagnosis and treatment of proliferative disease |
| 04/12/2000 | EP0991420A1 Modulation of the hypothalamic-pituitary-adrenal-adipose axis with leptin receptor ligands |
| 04/12/2000 | EP0991419A1 Treatment of infertility with leptin receptor ligands |
| 04/12/2000 | EP0991418A1 Method of modulating hypothalamic somatostatin release |
| 04/12/2000 | EP0991417A1 Complex formation between dsdna and oligomer of heterocycles |
| 04/12/2000 | EP0991413A1 Composition comprising a hydrolysed collagen protein and glucosamine for the treatment of arthroses |
| 04/12/2000 | EP0991325A1 Procede d'amelioration de l'efficacite d'un probiotique, preparation d'additis alimentaires et aliments pour animaux le contenant |
| 04/12/2000 | EP0991321A1 Tolerance to natural antibody antigens |
| 04/12/2000 | EP0991319A2 Treatment for diabetes |
| 04/12/2000 | EP0862440A4 Therapeutic use of hemoglobin in promoting wound healing |
| 04/12/2000 | EP0814838A4 Antigen presenting system and methods for activation of t-cells |
| 04/12/2000 | EP0809654B1 Calcitonin salmon analogues, their preparation, medicinal use and use as analytical agents |
| 04/12/2000 | EP0668776B1 Memory enhancing substances |
| 04/12/2000 | EP0452413B1 Generation and selection of novel dna-binding proteins and polypeptides |
| 04/12/2000 | EP0362218B2 IMPROVED METHOD FOR PRODUCING FACTOR VIII:c-TYPE PROTEINS |
| 04/12/2000 | CN1250484A Diagnosis and treatment of glaucoma |
| 04/12/2000 | CN1250480A Eukaryotic gene expression cassette and uses thereof |
| 04/12/2000 | CN1250479A Modulators of the function of receptors of the TNF/NGF receptor family |
| 04/12/2000 | CN1250471A Photochemical singlet oxygen generators having enhanced singlet oxygen yields |
| 04/12/2000 | CN1250381A Remedies for lymphocytic tumors |
| 04/12/2000 | CN1250379A Remedies for diabetes |
| 04/12/2000 | CN1250378A Pharmaceutical compositions |
| 04/12/2000 | CN1250377A Hydrophilic binary systems for the administration of cyclosporine |
| 04/12/2000 | CN1250376A Treatment of infarcts through inhibition of NF-KAPPAB |
| 04/12/2000 | CN1250055A Production of recombination human lactoferritin |
| 04/12/2000 | CN1051317C Displacement chromatography process and purified hemoglobin product |
| 04/12/2000 | CN1051224C Lyophilized bougie and producing process thereof |
| 04/11/2000 | US6048971 Recombinant human erythropoietin mutants |
| 04/11/2000 | US6048970 Prostate growth-associated membrane proteins |
| 04/11/2000 | US6048967 Blood compound associated with a nitroxide compound to prevent or alleviate the side effects of oxygen stress |
| 04/11/2000 | US6048966 Preventing blood loss using fibrinogenas a seal; incubation of fibrinogen with splitting enzyme with subseqent application of digested peptides to desired site of action |
| 04/11/2000 | US6048965 Polypeptide that controls the premature degradation of transcripts |
| 04/11/2000 | US6048964 Compositions and therapeutic methods using morphogenic proteins and stimulatory factors |
| 04/11/2000 | US6048963 Polynucleotides and polypeptides associated with benign prostatic hypertrophy |
| 04/11/2000 | US6048962 Mammalian protein allergen; for the diagnosis and treatment of mammalian allergic response |
| 04/11/2000 | US6048898 Synthesis of glatiramer acetate (copolymer-1) |
| 04/11/2000 | US6048889 Proline derivatives |
| 04/11/2000 | US6048888 Method and pharmaceutical formulation for treating benign prostatic hyperplasia |
| 04/11/2000 | US6048858 Heteroring containing a sulfonamide group |
| 04/11/2000 | US6048850 Method of inhibiting prostaglandin synthesis in a human host |
| 04/11/2000 | US6048844 Treatment of conditions and disease |
| 04/11/2000 | US6048843 Topical composition containing amino acid in combination with either interferon of thymidine derivatives for treating viral or inflammation diseases |
| 04/11/2000 | US6048840 Hypoglycaemic peptides |
| 04/11/2000 | US6048837 Dietetics |
| 04/11/2000 | US6048729 Animal transfected clonal cells for the expression of therapeutic products |
| 04/11/2000 | US6048726 Oligonucleotide which suppresses gene expression; for the treatment of inflammatory diseases, skin disorders and asthma |
| 04/11/2000 | US6048724 Producing mammalian transfected cell strain which expresses exogenous dna encoding erythropoietin and glucagons; for prevention or treatment of a condition in which insulin production or glucagon function is defective |
| 04/11/2000 | US6048720 Conjugates of a polypeptide and a biocompatible polymer |
| 04/11/2000 | US6048718 Mitochondrial polypeptide; for the treatment of cancer and nervous system disorders; anticarcinogenic agents |
| 04/11/2000 | US6048717 Enzyme inhibitor that prevents cleavage by immunoglobulin; for treatment of asthma and autoimmune disease |
| 04/11/2000 | US6048716 Microorganism polypeptide; for infection prevention bactericides; wound healing agents |
| 04/11/2000 | US6048711 Human G-protein coupled receptor polynucleotides |
| 04/11/2000 | US6048709 Polynucleotide sequence coding a endothelial marker polypeptide; for the detection and therapy of heart and vascular disorders |
| 04/11/2000 | US6048704 Microfibrillar protein purified from human tissue which binds vein tissue antibody; for treatment and diagnosis of human vein tissue blockage disease |
| 04/11/2000 | US6048702 Antibody which specifically binds to a oncogene modulating peptide; for the diagnosis and treatment of breast, prostate, or liver cancer; anticarcinogenic agents; antitumor agents |
| 04/11/2000 | US6048685 In vitro diagnostic assay employing HIV-2 antigens for the detection of HIV-2 specific antibodies |
| 04/11/2000 | US6048544 Treating muscular disorders, chronic fatigue syndrome, irritable bowel disorder, and fibromyalgia |
| 04/11/2000 | US6048536 Vaccine compositions |
| 04/11/2000 | US6048534 Methods and compositions for the selective regulation of chorionic prostanoids |
| 04/11/2000 | US6048529 PVA or PEG conjugates of peptides for epitope-specific immunosuppression |
| 04/11/2000 | US6048526 Monoclonal antibodies reactive with defined regions of the T cell antigen receptor |
| 04/11/2000 | US6048525 Implanting hematopoietic cells comprising t-lymphocyte with dna sequence that expresses thymidine kinase gene; administering ganciclovir or acyclovir; treating graft versus host disease |
| 04/11/2000 | US6048524 In vivo production and delivery of erythropoietin for gene therapy |
| 04/11/2000 | CA2174314C Electrophilic peptide analogs as inhibitors of trypsin-like enzymes |
| 04/11/2000 | CA2016663C Enzyme inhibiting peptide derivatives |
| 04/11/2000 | CA2016656C Enzyme inhibitors |
| 04/11/2000 | CA2009946C Pasteurized, purified von willebrand factor concentrate and a process for the preparation thereof |